Latest thinking on paruresis and parcopresis: A new distinct diagnostic entity?

Kuoch, Kenley L. J.; Austin, David W.; Knowles, Simon R.

doi:10.31128/ajgp-09-18-4700

Cited by 6 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 Australian research revealed that AP, or shy bladder syndrome, affects between 2.8% and 16.4% of the population, occurring more frequently in men (75.0%–92.0%) than in women (8.1%–44.6%). 2 Treatments such as antianxiety medication, behavioural therapy and even self-catheterisation using portable catheters are recommended in Europe and the USA when needed. Despite their effectiveness, these treatments still present unresolved issues, including adverse effects and potential drug dependence.…”

Section: Introductionmentioning

confidence: 99%

Chinese herbal medicine combined with cognitive–behavioural therapy for avoidant paruresis: a controlled trial

Liang,

Zhou,

et al. 2023

Gen Psych

View full text Add to dashboard Cite

BackgroundAvoidant paruresis is a common clinical condition in urology and psychosomatic medicine. However, it has limited treatment options that are safe and effective with few side effects.AimsOur study aimed to investigate the effectiveness and safety of the Chinese herbal Yangxin Tongquan decoction combined with cognitive–behavioural therapy (CBT) for avoidant paruresis.MethodsSixty-eight patients with avoidant paruresis were divided into a treatment group (33 patients) and a control group (35 patients). The control group was assigned 10 weeks of CBT and systematic desensitisation. In addition to CBT and systematic desensitisation, the treatment group was given the Chinese herbal Yangxin Tongquan decoction during the 10-week study. The Shy Bladder Syndrome Scale (SBS) and the Self-rating Anxiety Scale (SAS) were administered before and after treatment to measure any change.ResultsThe overall efficacy in the treatment group (n=30) was 80.0% vs 62.5% in the control group (n=33). Comparing pretreatment and post-treatment measures, both groups showed improvement in SBS scores and SAS scores (treatment group: t(SBS)=8.397, p(SBS)<0.001, t(SAS)=8.216, p(SAS)<0.001; control group: t(SBS)=6.802, p(SBS)<0.001, t(SAS)=5.171, p(SAS)<0.001). Moreover, both groups’ SBS and SAS scores changed significantly over time (SBS scores: Ftime=118.299, p<0.001; SAS scores: Ftime=92.114, p<0.001). However, the treatment group performed better than the control group (SBS scores: Ftime*group=5.709, p=0.020; SAS scores: Ftime*group=7.235, p=0.009).ConclusionsThe Chinese herbal Yangxin Tongquan decoction combined with cognitive–behavioural psychotherapy positively affects the treatment of avoidant paruresis without significant adverse effects.

show abstract

Section: Introductionmentioning

confidence: 99%